128-62-1
基本信息
纳可丁
诺司卡品
那可汀[鹼]
(S,R)-那可汀
(S,R)-诺司卡品
Capval
Lyobex
Vadebe
Ecasil
Terial
Nipaxon
nsc5366
Opianin
Vadebex
物理化学性质
外观性状 | 无色结晶性粉末或有光泽的棱柱状或片状结晶;无臭,无味。几乎不溶于水,微溶于乙醇与乙醚,溶于氯仿。 |
熔点 | 174-176 °C(lit.) |
比旋光度 | -200 º (c=1 in chloroform) |
沸点 | 532.6°C (rough estimate) |
密度 | 1.395 |
折射率 | 1.5614 (estimate) |
储存条件 | -20°C Freezer, Under Inert Atmosphere |
溶解度 | Practically insoluble in water, soluble in acetone, slightly soluble in ethanol (96 per cent). It dissolves in strong acids; on dilution of the solution with water, the base may be precipitated. |
酸度系数(pKa) | 7.8(at 25℃) |
形态 | neat |
颜色 | 正交棱镜或粗针 |
旋光性 (optical activity) | [α]20/D 200°, c = 1 in chloroform |
水溶解性 | 302.9mg/L(25 ºC) |
Merck | 13,6752 |
NIST化学物质信息 | Narcotine alkaloid(128-62-1) |
EPA化学物质信息 | 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-, (3S)- (128-62-1) |
安全数据
危险性符号(GHS) | GHS07 |
警示词 | 警告 |
危险性描述 | H302-H336 |
防范说明 | P301+P312+P330 |
危险品标志 | Xn |
危险类别码 | 22 |
安全说明 | 24/25 |
危险品运输编号 | 1544 |
WGK Germany | 3 |
RTECS号 | RD2625000 |
危险等级 | 6.1(b) |
包装类别 | III |
海关编码 | 29329990 |
毒害物质数据 | 128-62-1(Hazardous Substances Data) |
毒性 | cyt-ham:lng 100 mg/L ATSUDG (4),41,80 |
应用领域
图谱信息
那可汀(128-62-1)质谱(MS)那可汀(128-62-1)核磁图(1HNMR)那可汀(128-62-1)核磁图(13CNMR)那可汀(128-62-1)红外图谱(IR1)那可汀(128-62-1)红外图谱(IR2)那可汀(128-62-1)Raman光谱常见问题列表
Sigma opioid receptors Bradykinin Apoptosis
Noscapine (0-1000 μM; 0-96 hours; rat C6 glioma cells) treatment inhibits cell viability of rat C6 glioma in vitro in a dose- and time-dependent manner. Noscapine inhibits the viability of rat C6 glioma cells with an IC
50
of 250 μM at 72 hours.
Noscapine exposure causes abnormal S-phase reentry, increases mitotic arrest and results in excessive DNA accumulation.
Cylindromatosis increases the ability of noscapine to induce mitotic arrest and apoptosis. Cylindromatosis enhances the effect of noscapine on microtubule polymerization and promotes noscapine binding to microtubules.
Cell Viability Assay
Cell Line: | Rat C6 glioma cells |
Concentration: | 0 μM, 0.1 μM, 1 μM, 2 μM, 10 μM, 50 μM, 100 μM, 1000 μM |
Incubation Time: | 0 hours, 12 hours, 24 hours, 48 hours, 72 hours, 96 hours |
Result: | Inhibited cell viability of rat C6 glioma in vitro in a dose- and time-dependent manner. |
Noscapine (300 mg/kg; oral gavage; daily; for 15 days; athymic female mice) treatment reduces tumor growth in mice.
Animal Model: | Athymic female mice (nu/nu) (8-week-old) injected with rat C6 glioma cells |
Dosage: | 300 mg/kg |
Administration: | Oral gavage; daily; for 15 days |
Result: | Revealed a significant reduction of tumor volume. |